Results 11 to 20 of about 7,115 (188)

Activation of CD44/PAK1/AKT signaling promotes resistance to FGFR1 inhibition in squamous-cell lung cancer [PDF]

open access: yesnpj Precision Oncology, 2022
Lung cancer is the leading cause of cancer-related deaths worldwide. Fibroblast growth factor receptor 1 (FGFR1) gene amplification is one of the most prominent and potentially targetable genetic alterations in squamous-cell lung cancer (SQCLC).
Omar Elakad   +12 more
doaj   +2 more sources

GZD824 Overcomes FGFR1-V561F/M Mutant Resistance in Vitro and in Vivo

open access: yesCancer Medicine, 2021
Abnormallyactivated FGFR1 has been validated as a therapeutic target for differentcancers. Although a variety of FGFR inhibitors have shown benefit in manyclinical patients with FGFR1 aberration, FGFR1 mutant resistance such as V561Mmutation, has been ...
Jing Guo, Ke Ding, Ke Ding
exaly   +2 more sources

Fgfr1 inactivation in the mouse telencephalon results in impaired maturation of interneurons expressing parvalbumin. [PDF]

open access: yesPLoS ONE, 2014
Fibroblast growth factors (Fgfs) and their receptors (Fgfr) are expressed in the developing and adult CNS. Previous studies demonstrated a decrease in cortical interneurons and locomotor hyperactivity in mice with a conditional Fgfr1 deletion generated ...
Karen Müller Smith   +5 more
doaj   +2 more sources

Ponatinib as targeted therapy for FGFR1 fusions associated with the 8p11 myeloproliferative syndrome

open access: yesHaematologica, 2013
The 8p11 myeloproliferative syndrome is a rare, aggressive myeloproliferative neoplasm characterized by constitutively active FGFR1 fusion proteins that arise from specific chromosomal translocations and which drive aberrant proliferation. Although FGFR1
Andrew Chase   +3 more
doaj   +2 more sources

FGF8–FGFR1 signaling regulates human GnRH neuron differentiation in a time- and dose-dependent manner

open access: yesDisease Models & Mechanisms, 2022
Fibroblast growth factor 8 (FGF8), acting through the fibroblast growth factor receptor 1 (FGFR1), has an important role in the development of gonadotropin-releasing hormone-expressing neurons (GnRH neurons).
Venkatram Yellapragada   +6 more
doaj   +1 more source

FGFR1 and the Bloodline of the Vasculature [PDF]

open access: yesArteriosclerosis, Thrombosis, and Vascular Biology, 2005
Since the recognition of basicfibroblast growth factor (bFGF, FGF-2) and acidic FGF (aFGF, FGF-1) as proliferation and maintenance factors for endothelial cells in culture,1,2 much interest has arisen regarding their role as potential angiogenic factors in tumors and tissue healing in vivo.
van Hinsbergh, V.W.M., Rabelink, T.J.
openaire   +2 more sources

Immunomodulation via FGFR inhibition augments FGFR1 targeting T-cell based antitumor immunotherapy for head and neck squamous cell carcinoma

open access: yesOncoImmunology, 2022
Fibroblast growth factor receptor 1 (FGFR1) is overexpressed in multiple types of solid tumors, including head and neck squamous cell carcinoma (HNSCC).
Michihisa Kono   +15 more
doaj   +1 more source

FGFR1 regulates proliferation and metastasis by targeting CCND1 in FGFR1 amplified lung cancer [PDF]

open access: yesCell Adhesion & Migration, 2020
Aims: The analysis of the online databases revealed that CCND1 expression is correlated with poor prognosis in LSCC. We aimed to explore the function of CCND1 in tumor progression in LSCC.Main methods: The expression of mRNA was measured using qRT-PCR. Protein expression was assessed by Western blot.
Ying Yang   +3 more
openaire   +3 more sources

Diagnosis and Treatment of Clonal Myeloproliferative Neoplasms with Eosinophilia

open access: yesКлиническая онкогематология, 2020
Aim. Based on our own materials to characterize the clinical manifestations of hypereosinophilic states distinguishing between reactive eosinophilia (RE), clonal myeloproliferative neoplasms with eosinophilia (MPN-eo), and myeloproliferative variant of ...
Irina Semenovna Nemchenko   +6 more
doaj   +1 more source

FGFR1 amplification or overexpression and hormonal resistance in luminal breast cancer: rationale for a triple blockade of ER, CDK4/6, and FGFR1

open access: yesBreast Cancer Research, 2021
Background FGFR1 amplification, but not overexpression, has been related to adverse prognosis in hormone-positive breast cancer (HRPBC). Whether FGFR1 overexpression and amplification are correlated, what is their distribution among luminal A or B HRPBC,
Silvana Mouron   +8 more
doaj   +1 more source

Home - About - Disclaimer - Privacy